Expert Discusses Approval of First CAR T-Cell Therapy – OncLive
OncLive |
Expert Discusses Approval of First CAR T-Cell Therapy
OncLive OncLive: Can you please provide some background on this CAR T-cell therapy? Ferrara: This is a therapy for relapsed leukemia. If a type of leukemia does not respond to chemotherapy, which happens around 25% of the time, it's very unlikely to completely … Monroe Carell Jr. Children's Hospital at Vanderbilt to offer new cutting-edge treatment for type of pediatric leukemia |
